Cambridge Cognition Holdings Plc

COG

GB00B8DV9647

Cambridge Cognition Holdings plc is a neuroscience technology company. The Company develops and markets digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight, and NeuroVocalix. CANTAB Recruit is an online trial recruitment platform helping pharmaceutical and biotechnology companies identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease. CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in therapeutic areas from phases I - IV. Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone apps for high frequency data collection. It serves specialist contract research organizations, academic research institutions, and international healthcare providers.

Sector

Software

Calendar

2024-09-18 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Cambridge Cognition Holdings Plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.52 GBP

Average target price

2.075 GBP

Spread / Average Target

+299.04%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector System Software

	1st Jan change	Capi.
CAMBRIDGE COGNITION HOLDINGS PLC	+0.97%	20.12M
ZSCALER, INC.	-19.90%	26.51B
MONDAY.COM LTD.	-0.30%	9.04B
KPIT TECHNOLOGIES LIMITED	-9.42%	4.47B
WALKME LTD.	-25.68%	738M
TRAFFIC CONTROL TECHNOLOGY CO., LTD.	+2.35%	485M
XPERI INC.	-9.44%	430M
INSYDE SOFTWARE CORP.	-9.44%	266M
ZHENGZHOU TIAMAES TECHNOLOGY CO.,LTD	-29.61%	195M
HANGZHOU HOPECHART IOT TECHNOLOGY CO.,LTD	-44.02%	175M

System Software

Market Closed - London S.E. Other stock markets 11:35:02 2024-04-24 am EDT			5-day change	1st Jan Change
52 ^GBX	0.00%		0.00%	+0.97%

Apr. 23	Cambridge Cognition partly-owned spin-off gets GBP1.5 million funding	AN
Apr. 23	Cambridge Cognition's Spin-Out Company Closes Fundraise for Schizophrenia Drug	MT

Cambridge Cognition partly-owned spin-off gets GBP1.5 million funding	Apr. 23	AN
Cambridge Cognition's Spin-Out Company Closes Fundraise for Schizophrenia Drug	Apr. 23	MT
EARNINGS AND TRADING: Hostelworld boosts revenue and narrows loss	Mar. 21	AN
Cambridge Cognition Sets Up Scientific Advisory Board	Mar. 21	MT
Cambridge Cognition Holdings Plc Announces Formation of New Scientific Advisory Board	Mar. 21	CI
EARNINGS AND TRADING: Chamberlin loss narrows; Corero inks Latam deal	Feb. 21	AN
Cambridge Cognition, ActiGraph to Advance Digital Technologies for Brain Disorder Studies	Feb. 21	MT
Cambridge Cognition Holdings plc Announces New Strategic Partnership with ActiGraph	Feb. 21	CI
Synthomer predicts revenue decline amid challenges	Jan. 30	AN
Cambridge Cognition Holdings plc Announces Board Appointments, Effective February 1, 2024	Jan. 30	CI
EARNINGS AND TRADING: Cambridge Cognition launches AQUA solution	23-10-24	AN
Cambridge Cognition Holdings plc Announces Launch of Automated Quality Assurance Solution for Central Nervical System Clinical Trials	23-10-24	CI
AIM WINNERS & LOSERS: Eneraqua shares plunge on annual profit warning	23-10-11	AN
Cambridge Cognition Wins GBP1 Million Contract	23-10-11	MT
Cambridge Cognition jumps on GBP1 million contract win	23-10-11	AN
Cambridge Cognition Holdings plc Secures Significant Contract for a Sizeable Later Stage Clinical Trial, Following a Competitive Tender	23-10-11	CI
FTSE 100 Closes Up 0.07% Tuesday, Buoyed by Weak Pound	23-09-26	DJ
Cambridge Cognition Holdings Plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-26	CI
Cambridge Cognition swings to interim loss amid ballooning costs	23-09-26	AN
Cambridge Cognition Obtains GBP3 Million Term Loan; Shares Drop	23-09-26	MT
Cambridge Cognition Holdings plc Announces Revenue Guidance for Second Half and Full Year 2023	23-09-26	CI
Cambridge Cognition Holdings Plc announced that it has received £3 million in funding	23-09-25	CI
Cambridge Cognition inks GBP2 million contract on cancer therapy trial	23-06-13	AN
Cambridge Cognition Bags GBP2 Million Contract for Cancer Drug Study	23-06-13	MT
Cambridge Cognition Holdings plc Wins £2 Million Contract for Pivotal Cancer Therapy Trial	23-06-13	CI

Cambridge Cognition Holdings Plc

Equities

COG